In silico point mutation and evolutionary trace analysis applied to nicotinic acetylcholine receptors in deciphering...

Area of Science:

• Neuroscience
• Pharmacology
• Structural Biology

Background:

• Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels vital for neurotransmission in the CNS and PNS.
• nAChR dysfunction is linked to neurodegenerative diseases like Alzheimer's, Parkinson's, and schizophrenia, making them significant drug targets.

Purpose of the Study:

• To investigate ligand interactions with the pentameric alpha7 nicotinic acetylcholine receptor (α7nAChR).
• To identify specific residues involved in ligand binding and their sensitivity to antagonists.

Main Methods:

• Computational docking studies of diverse agonists and antagonists with an α7nAChR model.
• Virtual mutations of identified ligand-interacting residues.
• Evolutionary trace analysis to identify conserved residues near the binding site.

Main Results:

• Identification of potential ligand-interacting residues, including evolutionarily conserved ones like Ser34, Gln55, Ser146, and Tyr166.
• Virtual mutations revealed high sensitivity of these residues to antagonists.
• Evolutionary trace analysis corroborated docking findings by highlighting conserved residues near the ligand-binding site.

Conclusions:

• Specific amino acid residues in α7nAChR play a critical role in ligand binding.
• These identified residues are sensitive to antagonist binding, offering potential for targeted drug design.
• Computational and evolutionary analyses provide valuable insights into α7nAChR structure-function relationships for therapeutic development.